Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stena Line lays the keel for Stena Futura – the first of its NewMax ships

Stena Line has reached an important milestone in its fleet investment programme with the keel laying of the first NewMax vessel to be deployed on the Belfast-Heysham route. At the same time, the ferry’s name was disclosed: Stena Futura. On Friday 28 June, the keel laying ceremony of the first of the two all-new NewMax hybrid vessels took place in China Merchants Jinling Shipyard in WeiHai, China. Stena Futura, the chosen name for this ship, is one of two NewMax hybrid vessels that will play a key role in Stena Line’s journey to sustainable fuel as they will both be able to operate

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 147 – 1 JULY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 96/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 146 – 1 JULY 2024 Dampskibsselskabet NORDEN A/S – weekly report on share buy-back   On 25 April 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 26 April 2024 up to and including no later than 1 August 2024. For details, please see announcement no. 96 of 25 April 2024.   Under the share buy-back programme, NORDEN will purchase shares for

Ponsse´s new solutions at FinnMETKO 2024 exhibition in August, Jämsä, Finland

The 20th FinnMETKO exhibition will be held in Jämsä on 29–31 August 2024. You are welcome to visit our stand 862 and see our new forestry solutions and services, as well as our new product range. We will also arrange several logging demos every day.We will demonstrate new features to support forest machine operators’ daily work and to assist forestry entrepreneurs to follow up on the fleet’s profitability and productivity. We are also presenting a fossil-free material concept load space. Ponsse is the first forest machine manufacturer in the world to show a part of forest machine made of

Lumera acquires ITM to grow presence in UK market

ITM adds substantial UK customer base, key competence and consultancy resources. Stockholm, July 1, 2024 – Lumera, a leading insurtech company dedicated to the digital transformation of the European Life and Pensions industry, has entered an agreement to acquire ITM, an independent provider of data management and technology solutions serving the UK Life and Pensions markets. A major step in Lumera’s international growth strategy and the largest acquisition to date, ITM adds significant presence and capabilities to accelerate growth in the UK Policy Administration Systems (PAS) market.

RaySearch releases RayStation 2024B

RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company’s innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image import directly followed by deep-learning segmentation and fast automated plan adaptation.Adaptive radiation therapy involves continuous adjustment of the delivered radiation dose to account for changes in the patient anatomy throughout the course of treatment, which in most cases extends over several weeks. The adjustments are made to ensure the

Invitation to presentation of Bravida’s report for the second quarter 2024

Bravida’s report for the second quarter 2024 will be published 07:30 CET on 12 July 2024.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Åsa Neving. The presentation will be held in English and can be followed on the web or by phone. There will be room for questions in the telephone conference. Link to webcasthttps://ir.financialhearings.com/bravida-q2-report-2024/registerTelephone conference Register via the link below to participate in the telephone conference. After registration, you will receive a phone number and a conference ID

Genetic Analysis announces placement of a directed share issue of approximately NOK 4.97 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH OR NORWEGIAN LAW. Genetic Analysis AS (“GA” or the “Company”) is pleased to announce that it has successfully placed a directed issue and on basis of commitments

Kemira expands its water treatment offering to include activated carbon, acquiring Norit’s UK reactivation operations

Kemira Oyj, press release, July 1, 2024 at 10.00Kemira expands its water treatment offering to include activated carbon, acquiring Norit’s UK reactivation operations  Kemira has signed a definitive agreement to purchase Norit’s UK reactivation business from Purton Carbons Limited on June 28, 2024. This acquisition is the first step for Kemira in entering the activated carbon market for micropollutants removal.  Activated carbon is the most common technology to remove odor and taste in drinking water, as well as micropollutants including per- and polyfluoroalkyl substances (PFAS) in

Freetrailer sets new record with 1,278,166 rentals in the 23/24 financial year

Freetrailer breaks several rental records in the 23/24 financial year. · The total number of rentals increased to 1,278,166 · Highest number of rentals in a quarter with 400,106 in Q4 · Highest number of rentals in a week (week 18 in 2024) with 35,376 rentals. · The total number of trailers and electric cargo bikes 30/6-2024 was 4,876 units. · Most new rental products in a financial year with 1.241 units (22/23: 825 new units).The progress continued for the Freetrailer sharing economy platform in the financial year 23/24. With 1,278,166 rentals in the past 12 months, the

FlexQube receives an order worth $445 000

FlexQube has received an order for an existing customer in Mexico worth approximately $445 000. The order will be delivered at the end of the fourth quarter of 2024 and consists of cart transport products within FlexQube's mechanical concept.  The customer has continuously since 2021 expanded its fleet of cart transport systems via FlexQube. About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube offers solutions for cart-based material handling using a patented modular concept. FlexQube

Cell Impact will develop and supply a prototype forming tool to a leading European industrial supplier

Cell Impact AB (publ) has signed an agreement with a leading European industrial supplier with global operations in many different market segments.The deal concerns a prototype forming tool to be used by the customer for evaluation of Cell Impact Forming™, Cell Impact's unique and patented technology for manufacturing flow plates. The deal is yet another example of the interest in Cell Impact Forming and its advantages in flow plate production. The deal has a limited financial impact on Cell Impact's operating profit. Nevertheless, the agreement constitutes an opportunity for Cell Impact

Crunchfish and Tata Consultancy Services enter alliance agreement to offer offline payments for CBDCs

Crunchfish and Tata Consultancy Services (TCS) have entered into an alliance agreement targeting Central Bank Digital Currency (CBDC) projects around the world where Crunchfish will augment the Quartz solution for CBDCs with offline payments capabilities. A part of the Tata group, India's largest multinational business group, TCS has over 601,000 of the world’s best-trained consultants in 55 countries.[A black and white logo Description automatically generated]   Quartz™ provides foundational technology, tools and business components that harness the power of next-gen technologies

Rejlers contributes to successful concession for electricity connection of green steel mill

Rejlers has been a key partner in securing the concession for the connection of H2 Green Steel's steel mill in Svartbyn, Boden Municipality. As part of the assignment, Rejlers has been responsible for managing the necessary permits, including the grid concession, and has carried out a comprehensive constructability analysis. The industrial park, located in northern Sweden, will be an important location for large-scale production of fossil-free steel using hydrogen-based green energy.The new production process, in which hydrogen replaces coal in iron production, means significant reductions

White Pearl Technology Group publish Annual Report 2023

The annual report refers to the White Pearl Technology Group AB operations during the period January 1, 2023 through december 31, 2023.White Pearl Technology Group (WPTG), organisation no. 556939-8752, is a Swedish public limited company whose shares of series B are admitted to trading on Nasdaq First North Growth Market Sweden and are traded under the ticker WPTG B with ISIN code SE0019762477, since 29 th of June 2023. White Pearl Technology Group refer to the holding company and the 28 subsidaries in 2023 (thirthy subsidairies in 2024) that are part of the company group. AGM will be

BioStock: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0”

BioInvent recently announced promising clinical data for its lead cancer immunotherapy candidates, BI-1808 and BI-1206. The company hosted a Key Opinion Leader webinar to explain the results in detail, featuring insights from internationally recognized oncologist Dr Alexander Eggermont. According to Dr Eggermont, BioInvent’s candidates hold great promise for the future of immuno-oncology.Read the article at biostock.se: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0” - BioStock 

Zeqmelit® Planned to be Available in Pharmacies Starting September 1

The medication Zeqmelit® is planned to be available in pharmacies in Sweden from September 1, 2024. Launches in Norway and Finland are expected to follow shortly thereafter. In parallel, pre-launch activities are underway to prepare the market for an effective launch.AcuCort’s medication Zeqmelit® – a fast-dissolving oral film placed on the tongue for the treatment of severe to acute allergy –is currently in an intensive commercialization phase. Based on extensive pre-launch activities, the planned launch will take place on September 1, 2024, making the product available to patients. The

Bruhn NewTech welcomes Adelis Equity as partner and majority shareholder in the first step towards the creation of a leading European technology defence group

Bruhn NewTech, the leading provider of CBRN knowledge management software, announces Adelis Equity as new majority shareholder. Adelis will, through Adelis Equity Partners Fund III AB, support Bruhn NewTech in its next stage of its growth and product development. Bruhn NewTech marks the first milestone in Adelis’ establishment of a company group of leading niche software companies to support the protection of people and societies.Bruhn NewTech, the Danish provider of knowledge management software that increases societies readiness towards chemical, biological, radiological and nuclear (CBRN)

Compliance with Market Abuse Regulations

1 July 2024   Fidelity European Trust PLC (“the Company”)   LEI: 549300UC0QPP7Y0W8056   Compliance with Market Abuse Regulations   The Company wishes to notify the market that the closed period of the Company in relation to its half-yearly results for the period ending 30 June 2024 will commence on 1 July 2024 (today) and is anticipated to end no sooner than 31 July 2024.   The Company confirms that all inside information (as defined in the UK Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory

Compliance with Market Abuse Regulations

Fidelity Emerging Markets Ltd (“the Company”)   Compliance with Market Abuse Regulations     The Company wishes to notify the market that the closed period of the Company in relation to its annual results for the period ended 30 June 2024 will commence on 9 September 2024 and is anticipated to end no sooner than 9 October 2024.   The Company confirms that all inside information (as defined in the UK Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory information service.  Accordingly, in the absence of any new

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge will issue its Q2 Report 2024 on July 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.Fund managers, analysts and media are invited to participate in the conference call. To participate via teleconference, please register via this link . After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

Remedy Entertainment Plc: Share subscriptions based on stock options 2018 and 2019

Remedy Entertainment Plc     Stock exchange release       July 1, 2024, 9:00 a.m. EEST   Share subscriptions based on stock options 2018 and 2019 Between April 1 and May 31, 2024, a total of 16,500 Remedy Entertainment Plc’s new shares has been subscribed for with the company’s stock options 2018 and 2019. For subscriptions made with the stock options 2018 and 2019, the entire subscription price of EUR 120,250.00 will be entered in the reserve for invested unrestricted equity. After the trade registration the total amount of shares is 13,569,151. The shares subscribed for

Image System's business area RemaSawco receives an order from a Canadian partner of just under SEK 2.2 million

RemaSawco works with a partner in Canada who has now signed an agreement with a Canadian customer where RemaSawco's order value amounts to just under SEK 2.2 millionFor several years now, RemaSawco has collaborated with a partner in Canada for the North American market who has now signed an agreement with an end customer in Canada. RemaSawco's part of the agreement concerns the licensing of RemaSawco's world-leading system for board scanning, RS-BoardScannerQ, which can be used in all parts of the board handling process at a sawmill. The agreement also includes technical support during

There are no items matching the current filter
There are no more items matching the current filter
Back to top